Get alerts:Adjusted operating income rose 17% from the prior-year quarter, while adjusted earnings per share increased 12%, supported in part by the company’s share repurchases. U.S. Healthcare Solutions operating income increased 16% to $966 million. Excluding OneOncology’s contribution and the prior loss of the oncology customer, the company’s core business generated double-digit organic operating income growth, management said. Updated Outlook and Fiscal 2027 ConsiderationsFor fiscal 2026, Cencora now expects consolidated adjusted operating income growth of 13% to 14%. It projects U.S. Healthcare Solutions operating income growth of 14.5% to 15.5%, International Healthcare Solutions operating income growth of approximately 9%, and Other operating income growth of approximately 10%.